| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |